Pfizer's Activist Battle Might Fizzle---but Its Stock Probably Won't
The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
